Prescribed to prevent blood clots and stroke, Xarelto (rivaroxaban) is an oral anticoagulant medication that was approved by the U.S. Food and Drug Administration (FDA) in November 2011. Over the years, the FDA has expanded the approved uses for Xarelto, approving it to treat other serious conditions caused by blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
When Xarelto was first introduced to the U.S. market, it was touted as a “next generation” anticoagulant that was safer than older blood thinners (like warfarin).
Since then, however, Xarelto has been linked to some severe, potentially deadly complications.
Those who have been hurt after taking Xarelto may have various legal options for seeking compensation and holding negligent pharmaceutical companies liable. A lawyer at Bell & Pollock, P.C. is ready to review your potential Xarelto claim, answer your questions and help you take the right steps to get on the road to justice and recovery.
Listen To Our Radio Show About Xarelto Here:
Call (720) 580-4294 or Email Our Firm For Clear Answers about Your Potential Xarelto Claim
Initial consultations are free, and we do not charge any fees for our services unless compensation is secured for your claim. This means that you have nothing to lose by reaching out to discover more about your rights and legal options.
Xarelto Injuries & Complications
Xarelto Drug Injury Attorney
Made by Bayer AG (Bayer) and marketed by Janssen Pharmaceuticals (Janssen), Xarelto has been linked to a number of serious risks, some of which can be life-threatening. These include (and may not be limited to):
Uncontrollable bleeding – In most cases, this hemorrhaging involves gastrointestinal bleeding and/or cerebral hemorrhaging. Unlike other modern anticoagulants (such as Pradaxa), Xarelto does NOT have an antidote to stop these uncontrollable bleeding events. This makes Xarelto bleeding complications especially critical and deadly, as there is no standard protocol for treating and stopping them.
Stevens-Johnson syndrome (SJS) – As a severe and painful skin condition, SJS damages the mucous membranes and is deadly in about 10 percent of patients. Xarelto patients with the highest risk of developing this complication include males between 20 and 40 years old and/or those with a family history of SJS.
Wound infections – Xarelto has also been reported to increase the risk of developing serious infections following hip and knee replacement surgeries. These infections can cause wound reopening and painful abscesses.
Hepatitis – A disease marked by liver inflammation, hepatitis is most likely to develop in female Xarelto patients, as well as those who are over the age of 60, who are taking Xarelto in conjunction with Cordarone and/or who are within their first month of starting a course of Xarelto.
Xarelto comes with black box warnings, the most serious level of FDA warnings, to warn about these potentially life-threatening side effects. Nevertheless, many people have already been hurt by this drug – and many more face a significant risk of developing serious Xarelto injuries.
Xarelto Lawsuits & Recoveries: How an Attorney Can Help
Thousands of Xarelto lawsuits have already been filed against Bayer and Janssen, alleging that these companies:
Failed to properly assess the safety and risks associated with Xarelto before bringing it to market
Misrepresented the efficacy of Xarelto and downplayed its risks
Provided inadequate safety warnings on the drug’s packaging and labels
Failed to warn the public that there is no antidote for Xarelto bleeding events.
While Bayer and Janssen have already paid out tens of millions of dollars to resolve a number of Xarel